Substance
USTEKINUMAB
Global reference: every product and company linked to this substance.
- cas: 815610-63-0
- ncit: C84237
- rxnorm: 847083
- unii: FU77B4U5Z0
CNTO 1275 · CNTO-1275 · STELARA · TT-20 · ustekinumab [INN] · USTEKINUMAB [JAN] · USTEKINUMAB [USAN] · Ustekinumab [WHO-DD]
Revenue by product (2)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| JOHNSON & JOHNSON COMMON STOCK | STELARA | Q2 2026 | $740.0M |
| JOHNSON & JOHNSON COMMON STOCK | STELARA | Q2 2026 | $740.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (2)
- STELARA · JOHNSON & JOHNSON COMMON STOCK
- STELARA · JOHNSON & JOHNSON COMMON STOCK